In this Issue:
This is our most recent review of alternative strategies for treatment resistant AMD and predominantly the impact of switching to alterative anti-VEGF agents, dose escalation and combination therapy.
Commentary has been provided by Associate Professor Lawrence Lee.
Please login below to download this issue (PDF)